Global Peptide Therapeutics Market 2019-2023

The peptide therapeutics market size will grow by over USD 16 billion during 2019-2023. This report offers an analysis of the market based on RoA (parenteral, oral, and others). This peptide therapeutics market research report further presents in-depth insights into the growth prospects of the market across the Americas, APAC, and EMEA. The report analyzes the market’s competitive landscape and offers information on several companies including Eli Lilly, Novo Nordisk, Sanofi, Takeda Pharmaceutical, and Teva Pharmaceutical.

Below are some of the key findings from the peptide therapeutics market analysis report

See the complete table of contents and list of exhibits, as well as selected illustrations and example pages from this report.

Get a FREE sample now!

Global peptide therapeutics industry overview

A significant part of the peptide disintegrates before reaching the target as peptide therapeutics has a low half-life. This compels patients to take the drug frequently. Pharmaceutical companies are trying to improve the half-life of peptides through advanced peptide-based therapeutics. For instance, PEGylation is a process of attaching polyethylene glycol to peptides or proteins to enhance the pharmacokinetics of peptide drugs. The adoption of such drugs with extended half-life is one of the critical reasons that will drive growth in the peptide therapeutics market in the next five years.

The growing strategic collaboration among market players for R&D in novel therapies has driven the rate of drug approvals over the time. Collaborations enable them to conduct studies in specific regions, transfer technology, and ease the approval process at a regional level. The increasing focus on R&D and collaborations is identified as one of the critical peptide therapeutics market trends that will boost market growth at a CAGR of almost 9% during the forecast period.

Top peptide therapeutics companies covered in this market research report

The peptide therapeutics market is fragmented. Market players are forming alliances with research organizations to formulate various peptide-based drugs. By offering a complete analysis of the market's competitive landscape and with information on the products offered by the companies, this peptide therapeutics market forecast report will allow the clients to identify new growth opportunities and design innovative strategies to improve their share in the market.

The report offers a complete analysis of various companies including:

• Eli Lilly
• Novo Nordisk
• Sanofi
• Takeda Pharmaceutical
• Teva Pharmaceutical

Peptide therapeutics market segmentation based on geographic regions

• Americas
• APAC
• EMEA

A comprehensive study of the growth opportunities in the peptide therapeutics market indicates, the Americas will contribute to the highest market share of this market throughout the forecast period.  The increasing number of biosimilars is one of the primary reasons for the high growth of the peptide therapeutics market in this region.

Peptide therapeutics market segmentation based on RoA

• Parenteral
• Oral

The parenteral segment will account for the highest market share in the peptide therapeutics market due to the rapid absorption of drugs through parenteral RoA and avoidance of drug loss through the first-pass metabolism. This industry report offers valuable peptide therapeutics market insights on all the RoA segments that contribute to the growth of the market.

Key highlights of the global peptide therapeutics market for the forecast years 2019-2023:

• CAGR of the market during the forecast period 2019-2023
• Detailed information on factors that will accelerate the growth of the peptide therapeutics market during the next five years
• Precise estimation of the global peptide therapeutics market size and its contribution to the parent market
• Accurate predictions on upcoming trends and changes in consumer behavior
• The growth of the peptide therapeutics industry across various geographies such as the Americas, APAC, and EMEA
• A thorough analysis of the market's competitive landscape and detailed information on several vendors
• Comprehensive details on factors that will challenge the growth of peptide therapeutics companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch